Remgro posts $307 million half-year earnings; Mediclinic and Rainbow boost results

Stellenbosch-based South African investment holding company Remgro Limited, controlled by South Africa’s richest person and Africa’s second-richest individual Johann Rupert, reported better-than-expected results for the six months ended December 31, 2025. The group’s headline earnings exceeded $300 million for the first half of its 2026 fiscal year, reflecting steady improvements across its diverse portfolio.

Remgro earnings rise 38.8 percent

According to Remgro’s interim report, headline earnings rose 38.8 percent, climbing from R3.73 billion ($221.2 million) in the first half of 2025 to R5.18 billion ($307 million) in the corresponding period of 2026. The growth follows continued gains from the previous year and reflects the company’s focus on careful capital allocation, portfolio management, and active collaboration with investee companies to strengthen operational results and long-term value.

Remgro CEO Jannie Durand highlighted the company’s performance: “We are encouraged by the consistent improvements across our portfolio. The results reflect the quality and resilience of our investee companies and the foundations we have built over the past several years. By simplifying and focusing our portfolio, management teams can deliver stronger operational outcomes. We believe the portfolio is well positioned for further progress, supported by disciplined capital allocation and close partnerships with our teams.”

Mediclinic, Rainbow Chicken lift profits

Operational improvements underpinned the rise in earnings. Mediclinic Holdings added R485 million ($28.7 million), Rainbow Chicken contributed R280 million ($16.6 million), Community Investment Ventures Holdings Proprietary added R264 million ($15.7 million), and Heineken Beverages Holdings contributed R166 million ($9.8 million). TotalEnergies Marketing South Africa added R330 million ($19.6 million), reflecting a one-off pipeline cost refund. Lower finance costs of R95 million ($5.63 million) also helped, while RCL Foods Limited saw a R240 million ($14.2 million) decline due to weaker sugar unit results.

Strong cash flow generation continued, boosted by a 34 percent rise in dividends from investee companies, totaling R2.43 billion ($144.2 million), excluding a R2.66 billion ($158 million) CIVH pre-implementation dividend received after the CIVH/Vodacom transaction. Remgro’s indicative net asset value per share increased 1.6 percent, or 3.4 percent when adjusted for distributions, from R292.34 ($17.34) at June 30, 2025, to R297.03 ($17.62) at December 31, 2025.

Remgro completes strategic asset deals

The period included strategic portfolio moves. Remgro reached a non-binding agreement with MSC Mediterranean Shipping Company SA to restructure Mediclinic holdings, potentially giving Remgro full control of Mediclinic’s Southern African operations, while MSC would assume the Swiss Hirslanden business. The deal is based on a 1:1 equity value exchange aligned to Remgro’s June 2025 INAV and awaits regulatory approval.

Further portfolio optimization included the completion of the CIVH/Vodacom transaction, providing exposure to Vodacom-contributed assets and a R2.66 billion ($158 million) pre-implementation dividend. Remgro also sold its remaining stake in British American Tobacco and a portion of its FirstRand holding for R4.88 billion ($290 million).

The company declared an interim dividend of R1.73 ($0.10) per share, up 80.2 percent, and previously paid a final dividend of R2.48 ($0.14) per share, a special dividend of R2 ($0.11) per share, alongside unbundling its eMedia Holdings Limited investment.